Skip to main navigation Skip to search Skip to main content

Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: Beyond Ibrutinib

Research output: Contribution to journal › Review Article › Other › peer-review

Original languageEnglish
Pages (from-to)761-773
Number of pages13
JournalHematology/Oncology Clinics of North America
Volume35
Issue number4
DOIs
Publication statusPublished - Aug 2021
Externally publishedYes

Keywords

  • BTK inhibitors
  • CLL
  • Efficacy
  • Next-generation BTK inhibitors
  • Resistance
  • Side effects
  • Toxicity

Cite this